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Copper is relevant to human nutrition because
it is both essential and toxic depending on
the dose and duration of exposure. Ingestion
of high Cu doses induces acute effects in the
gastrointestinal tract, mainly in the stomach
(Furukawa and Hatano 1998; Kayashima et al.
1978; Niijima et al. 1987; Wang and Borison
1951), whereas chronic effects from long-term
overexposure results mainly on Cu accumula-
tion in the liver and liver damage (Bremmer
1998). Reports of acute Cu intoxication in
humans are infrequent (National Research
Council 2000; Ross 1955; Spitalny et al. 1984;
Wyllie 1957); the possibility that low Cu con-
centrations, such as those contained in drink-
ing water, may induce acute adverse effects in
humans was raised in the early 1980s and
1990s and quickly became a concern of health
authorities and regulators. Most natural drink-
ing waters have Cu concentrations not exceed-
ing a few milligrams per liter; however, soft,
acidic waters, especially when going through
new Cu pipes, may deliver higher amounts of
Cu (National Research Council 1980).
Anecdotal and accidental random events where
variable concentrations of Cu was related to
acute gastrointestinal symptoms have appeared
in the literature (National Research Council
2000; Ross 1955; Spitalny et al. 1984; Wyllie
1957), but the exact responses and their distri-
bution at a given dose within a population
were unknown. The current World Health
Organization (WHO) provisional guideline
value for drinking water of 2 mg Cu/L is based
on acute gastrointestinal symptoms that are
reversible in nature (WHO 1993, 2003).
Over the past decade, systematic con-
trolled randomized studies have characterized
the full response to acute Cu exposure in
drinking water, deﬁning the ﬁrst adverse effect
rather than toxic effects (Araya et al. 2001;
Olivares et al. 2001; Pizarro et al. 1999). In
these studies, clinical assays using controlled
exposure were performed including asympto-
matic participants 18–60 years of age, bal-
anced by sex, who were exposed to a single
bolus of different waters containing Cu sulfate
in concentrations ranging from 0.01 to 12 mg
Cu/L. The ﬁrst and most frequent symptom
reported was nausea, which was transient,
appearing mainly within 15 min after inges-
tion (Araya et al. 2001; Gotteland et al. 2001;
Olivares et al. 2001; Pizarro et al. 1999). The
no observed effect level (NOEL) was 2 mg
Cu/L, and the lowest observed adverse effect
level (LOAEL) for nausea was 4 mg Cu/L
(Olivares et al. 2001). At testing concentra-
tions of up to 12 mg Cu/L, the authors
reported that nearly one-third of the subjects
remained asymptomatic. Vomiting was
observed in 11.5% of the study subjects and
was ﬁrst reported at 6 mg/L, showing a 2-fold
increase when the Cu concentration reached
10–12 mg Cu/L. Diarrhea and abdominal
cramps were rare within the range of concen-
trations studied (Araya et al. 2001; Gotteland
et al. 2001; Olivares et al. 2001; Pizarro et al.
1999). Using these dose–response curves and
the 95% confidence intervals (CI), the Cu
concentration at which 5% of the population
would experience nausea was 2.0 mg Cu/L for
the crude initial response and 4.2 mg Cu/L
for the nausea response confirmed by repeat
testing (Olivares et al. 2001). Another study
emphasizing the interindividual variability of
responses across countries included volunteers
from the United States, Northern Ireland, and
Chile. Using the pooled data obtained in the
three countries and statistical significance to
define a level, the NOEL and LOAEL for
water were determined to be 4 and 6 mg
Cu/L (Araya et al. 2001).
Because an epidemiologic study using
natural exposure to Cu in water would be dif-
ficult to carry out, we decided to conduct a
controlled exposure study in a community
whose members maintained living conditions
as close to real life as possible.
Materials and Methods
Study design. This randomized, double-blind
community intervention trial was designed to
evaluate differences in the report of gastro-
intestinal symptoms in subjects exposed
during 2 months to Cu concentrations of
< 0.01 mg/L [usual Cu concentration in tap
water in Santiago, Chile (Troncoso et al.
1997)], 2 mg/L [WHO provisional-guideline-
value set in 1998 (WHO 2003)], 4 mg/L
[concentration at which gastrointestinal symp-
toms were signiﬁcantly increased in previous
controlled clinical trials (Araya et al. 2001;
Olivares et al. 2001)], or 6 mg/L [concentra-
tion at which vomiting was first reported
(Araya et al. 2001; Olivares et al. 2001)].
Nausea, vomiting, diarrhea, and abdominal
pain were defined outcome variables. The
2-month exposure allowed for assessing the
effect of time, and it was considered safe from
potential chronic adverse effects. Participating
families continued living at home, carrying
out customary activities. Daily water con-
sumption and symptoms were recorded in
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between time of Cu consumption and appear-
ance of symptoms was not controlled. One
person per household (usually the mother)
ensured that diaries were filled every night.
Twelve trained ﬁeld workers visited each fam-
ily every second day, reviewing data recorded
and delivering bottles containing the stock
solution to be used for water preparation.
Two communities were selected in south-
eastern Santiago on the basis of their sizes,
and all houses were censused, including gath-
ering general information and identifying
potential candidates for the study. Houses in
both communities were built as a group more
than 13 years before; they shared the city
water source and all had Cu pipes that had
not been modified or changed in the last
5 years. Because the intervention consisted of
preparing at home a “test water” to be con-
sumed by all family members, sample selec-
tion was by family, including population
≥ 18 years of age (Figure 1). Exclusion criteria
were deﬁned a priori: a) severe chronic illnesses
requiring multiple chronic medication; b) alco-
holism (> 120 mL alcohol/day); c) smoking
more than 40 cigarettes/day; and d ) con-
sumption of drugs. Eight families met these
criteria; also, 15 additional families moved to
another area. After two meetings with the
community in which we explained the proto-
col and invitited them to participate, 441
families signed an informed consent (one per
participant) and were randomized (using a
computer-generated random list) to receive
< 0.01, 2, 4, or 6 mg Cu/L, representing a
total of 1,365 individuals. No families
dropped out of the study during the 2-month
observation period. 
Two persons knew the randomization list,
the one who generated it and the one who pre-
pared Cu stock solutions. Because of difﬁcul-
ties in masking Cu taste in water, some
individuals were expected to taste the Cu at
higher concentrations; participants were care-
fully instructed not to share their perceptions
with ﬁeld workers or other persons. During a
2-month pilot phase, families received placebo
water (< 0.01 mg Cu/L), and we validated pro-
cedures and forms. Data obtained during this
period provided basal information for sample
size calculation. The Committee of Ethics for
Research in Humans of the Institute of
Nutrition and Food Technology (INTA),
University of Chile, approved this protocol. An
International Technical Advisory Committee
also reviewed ethical aspects of the protocol.
All volunteers received written and oral infor-
mation about the protocol and were free to
refuse continuing in the study at any time.
Test waters. Twice per week, a box contain-
ing eight 80-mL screw-cap bottles of similar
external appearance, coded by color, was deliv-
ered to each family; bottles contained a stock
solution of Cu sulfate (Merck, Darmstadt,
Germany; pro analysis grade) in amounts to
reach the concentration 2, 4, or 6 mg Cu/L
when diluted to 10 L with tap water. Water for
home consumption was prepared by pouring
the stock solution into a graduated 20-L con-
tainer (provided by the researchers) and ﬁlling it
to 10 L with tap water. Participants were
instructed to agitate the container before drink-
ing the water, drink the water when they were
at home, and not share it with visitors. The
same person that prepared the test water was
also responsible for maintaining stock solutions
out of reach of children and adults.
The actual Cu content in stock solutions
was measured daily, whereas in home-prepared
water this was performed once per week by
means of unexpected visits to the households,
either early in the morning, at mid-day, or in
the evening. Cu was measured by atomic
absorption spectrophotometry (model 2280;
Perkin Elmer, Norwalk, CT, USA). The
national system responsible for tap water in
Santiago, Empresa Metropolitana de Obras
Sanitarias (EMOS), provided tap waters used at
INTA laboratories and in the community.
Quality of tap water was tested at the INTA
once, following U.S. Environmental Protection
Agency protocol (Troncoso et al. 1997).
Because water was prepared and main-
tained at home, potential bacteriologic conta-
mination was investigated in a subsample of
179 randomly chosen households, once per
household. Sampling was distributed along the
2-month survey. We used mesophilic aerobic
counts (MAC), total coliform counts (TCC),
and fecal coliforms as indicators of bacterial
contamination. These parameters were deter-
mined by means of routine procedures
(Downes et al. 2001; Eaton et al. 1995).
Water consumption. Recording of con-
sumption of ﬂuids indicated the number and
size of glasses, cups, and soup bowls, includ-
ing the approximate amount left over;
300-mL mugs were given to participants, and
soup bowls and cups used were measured at
the beginning of the survey.
Health survey. For symptom recording,
participants ﬁlled out the diary choosing from
a list based on previous studies, validated dur-
ing the pilot phase, that included the four
symptoms defined as outcomes and the fol-
lowing symptoms that blinded the subject as
to the variables of interest [being energetic
(a positive effect assigned to Cu), lack of
energy, cough, headache, backache, chest pain,
others). Operational deﬁnitions of symptoms
were provided during the initial meeting and
again during home visits. Participants were
instructed to discontinue the test water and
use plain tap water for 48 hr when they expe-
rienced any symptom included in the list. At
the end of the 48-hr period, they could con-
tinue drinking the assigned water. If symp-
toms appeared again, subjects were instructed
to discontinue the assigned test water perma-
nently and consult the full-time (research)
physician located in the community. If symp-
toms persisted, they should seek help at the
local emergency service. Two physicians
belonging to the research team were always on
call during the study period.
Quality assurance of field operation and
data entry. In addition to ﬁeld workers, a ﬁeld
supervisor worked every day in the commu-
nity. Data collected were taken to INTA daily
and reviewed to detect missing values. Three
times per week, data were reviewed again with
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Figure 1. Flow chart showing procedure used to generate the study groups.
2,150 Families identified in the two communities
1,375 Families agreed to answer census form
464 Families fulfilled inclusion criteria and were accepted to participate
8 Families fulfilled exclusion criteria
15 Families moved out of the area prior to
beginning of protocol
441 Families incorporated to protocol
Randomization
Group 0
124 families
(343 individuals)
Group 2
111 families
(327 individuals)
Group 4
105 families
(355 individuals)
Group 6
101 families
(340 individuals)a computational supervisor to detect missing
data and errors and to correct them whenever
possible. Data were entered into the computer
at the end of the collection period, corrected,
and validated before analysis.
Sample size. Pilot phase data showed a
basal prevalence of total gastrointestinal symp-
toms (the four outcomes deﬁned for this study)
of 5%. Using a power of 80% and a probabil-
ity of 5%, the sample size required to detect a
change in frequency from 5% to 15% was
141 families/group (EPI INFO 6.0; Centers
for Disease Control and Prevention, Atlanta,
GA, USA). Estimating 5% dropout, we set the
ﬁnal number of families per group at 150.
Analysis of results. We used Cu concentra-
tion in drinking water as an independent vari-
able. Daily volume of water ingested was
analyzed as “total water,” “mixed water” (infu-
sions, soups, and others), and “plain water”
(test water). Dependent variables were nausea,
vomiting, diarrhea, abdominal pain, and total
gastrointestinal symptoms. All subjects were
included in the analyses; when diaries were not
completed, the data were labeled as “missing.”
Statistical analysis included analysis of variance
(ANOVA), chi-square test, and Fisher’s test.
Hazard associated with Cu exposure was cal-
culated by counting-process analysis using
S-Plus 6.0 software for Windows (Insightful
Corporation, Seattle WA, USA).
Our initial approach was to analyze only
those subjects in the randomized groups that
followed the protocol instructions, thus gener-
ating data under quasi-experimental condi-
tions. However, this omitted an important
proportion of the information because many
participants’ registered information was incom-
plete. We sought expert advice, and a post hoc
data assessment led us to choose the counting
process (S-Plus 6.0). This analysis did not fol-
low the randomized groups but improved the
assessment of the dose–response curve after
controlled exposure, allowing individuals to
remain present every time they recorded data;
in the counting process, each subject is treated
as an observation of a Poisson process. A cen-
sored subject is counted per event, that is, the
time of symptom report, even when the rest of
the data are incomplete; thus, all participants
remained in the analyses and were counted as
many times as they were at home, ingested test
waters, and ﬁlled out their diaries. Proportional
hazard models derived by this process allowed
predicting hazard ratios for different exposures
(Cu concentration measured in water at home)
and covariate conditions. Model information
used for dependent variable was start–stop for
an event; the censoring variable was the report
of outcome(s). Because the risk of event
decreased after repeated exposure, data were
stratiﬁed by the variable “time.” Seven-day risk
intervals were generated; Cu concentration
assigned to each interval and to each occurring
event was the value obtained in the weekly
measurement in home-prepared waters. Thus,
the 1,365 individuals surveyed for 63 days
yielded 85,995 person-days of exposure; the
number of events detected resulted in a total of
13,354 risk intervals, which were used for the
counting-process analysis. Covariates were sex,
age, total daily ﬂuid volume, volume ingested
as plain water (on the day of event), volume
ingested as mixed ﬂuids (on the day of event),
and the weekly Cu concentration value
obtained from measures of home-prepared
water. Multiple models were calculated to
assess the potential effect of different covariate
sets on the relative risk (RR) estimates for a
given Cu concentration. In order to express the
risk due to Cu exposure, holding other vari-
ables constant, we estimated the RR [95%
conﬁdence interval (CI)] due to an increase of
Cu exposure and kept the no-exposure groups
as the reference risk value.
Results
Comparability of enrolled and censused fami-
lies. Families and individuals that fulfilled
entry criteria were assigned to the intervention
groups as shown in Figure 1. There were no
significant differences in sociodemographic
indicators measured between families who
participated and those who did not. All
enrolled families and subjects (n = 1,365) pro-
vided data throughout the study period. No
individuals were withdrawn because of viola-
tions to the protocol.
Comparability of intervention groups.
Randomization resulted in similar groups for
the analyzed variables. Baseline demographic
characteristics and behaviors that would mod-
ify patterns of drinking water were similarly
distributed in the four groups (Table 1).
Bacteriologic study. Water was clean by
EMOS contemporary data for the study area.
Fecal coliforms were not detected; 22 of 179
(12.3%) home water samples had either MAC
or TCC positive, and in 5 of 179 (2.8%) both
indicators were positive (2, 2, and 1 families in
0, 2, and 6 mg Cu/L groups, respectively).
Because bacteriologic evaluations were done
once per family and symptom report had low
frequency, it was not possible to analyze
results using data obtained during the week of
bacteriologic sampling. We found no associa-
tion between the proportion of individuals
that reported symptoms or the total number
of symptoms reported and at least one positive
parameter in the bacteriologic study. In fami-
lies in whom both parameters were positive,
TCC was significantly associated with total
symptom report (p = 0.0012, Fisher’s test).
Adherence to the assigned group. Mean Cu
concentration measured in test waters prepared
at home, ﬂuid intake, and mean daily dose of
Cu received by the study subjects are shown in
Table 1. Individual daily water consumption
had signiﬁcant day-to-day variability (ranging
from 0 to 6 L/day, in one person), but inter-
group differences were not significant,
expressed either as total, plain water, or mixed
waters. Week-to-week fluid intake along the
9 study weeks did not reveal signiﬁcant differ-
ences (ANOVA). On one occasion, weekly
measurement of Cu concentration in home-
prepared waters showed two families whose
water Cu concentrations were different from
the expected values: one had 2 mg Cu/L
instead of < 0.01 mg Cu/L, and the other had
2 mg Cu/L instead of 4 mg Cu/L. Information
obtained from these families revealed that they
decided to interchange one stock solution bot-
tle in order to share the potential “beneﬁts” of
having more Cu in their drinking water. The
Cu concentration measured in test waters at
home was > 6 mg Cu/L (range, 7–13 mg/L) in
8,043 (out of 85,996) occasions, affecting 417
of 1,365 participants. 
Health survey. The number of families
enrolled were fewer than the estimated sample
size; however, the greater frequency of symp-
toms reported in the survey (in comparison
with the prevalence obtained in the pilot
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Table 1. Characteristics of the group, Cu concentration in test waters, Cu intake in waters, and test water
consumption.
Groups by Cu concentration in water (mg/L)
0( n = 343) 2 (n = 327) 4 (n = 355) 6 (n = 340)
Age (years; mean ± SD) 37.4 ± 14.5 36.9 ± 13.8 37.0 ± 15.0 38.5 ± 15.3
Female [n (%)] 184 (53.6) 161 (49.2) 166 (46.8) 162 (47.6)
Out of home (%)a 73.8 70.3 71.0 71.5
Schooling < 8 years (%)b 46.7 45.0 46.5 45.6
[Cu] (mg/L; mean  ± SD)c 0.05 ± 0.16 2.02 ± 0.25 3.71 ± 0.8 5.77 ± 1.0
Cu intake (mg/day; mean ± SD)d 0.08 ± 0.31 3.6 ± 1.4 6.9 ± 2.8 11.0 ± 4.4
Fluid intake [L/day; median 
(25th percentile–75th percentile)]e
Total 1.7 (1.3–2.3) 1.7 (1.4–2.2) 1.7 (1.3–2.2) 1.8 (1.4–2.3)
Mixed water 1.3 (1.0–1.7) 1.4 (1.1–1.7) 1.3 (1.0–1.7) 1.4 (1.1–1.8)
Plain water 0.4 (0.1–0.7) 0.4 (0.1–0.6) 0.35 (0.1–0.6) 0.41 (0.2–0.7)
There were no statistically signiﬁcant differences in the general characteristic among groups.
aPercentage of subjects ≤8 hr out of home, obtained from the median of hours absent from home per individual per weekdays.
bPercentage of subjects with < 8 years of schooling (eight years of education represents a complete basic school education in
the Chilean educational system). cCu concentration in water prepared at home. dCu intake from water prepared at home.
eFluid intake was calculated from average daily ﬂuid consumption for each start–stop period (counting-process analysis).phase) allowed statistical analysis and detection
of signiﬁcant differences. Traditional analysis
of this type of data consists of determining the
proportion of responders in the study group,
because persons that repeat their responses can-
not be treated as independent observations. In
turn, analysis of responses does not take into
consideration the fact that one individual may
report more than one symptom, and symp-
toms more than once. Characteristics of the
individuals, Cu concentration in test waters,
and Cu and water consumption are shown in
Table 1, whereas the proportion of responding
individuals appear in Table 2. Of the 1,365
individuals, 222 reported at least one symptom
in 665 occasions, providing a total of 794
symptoms; 16.3% of surveyed individuals were
“responders,” that is, they reported at least one
symptom at least once. Individuals of group 0
represented 2.9% of these responders, provid-
ing 18% of the total number of symptoms
reported during the study. “Responders” were
more frequently women (64.2%, χ2 = 70.84,
p = 0.0000). Only 2.6% of responses were
obtained from individuals ≥ 60 years of age;
although there were no signiﬁcant differences
by age interval, comparison of responses
obtained in the ﬁrst and third terciles for age
gave an odds ratio of 0.41. Individuals who
ingested < 500 mL test waters/day represented
< 1% in all four study groups. Using chi-square
analysis, symptom report increased signiﬁcantly
over the basal prevalence at 4 and 6 mg Cu/L,
whereas there were no differences between
4 and 6 mg Cu/L (Table 2). Abdominal pain
and nausea were the most frequently reported
symptoms. Distribution of the total number
of responses reported during the 2-month
controlled Cu exposure expressed as percent-
age of total symptom report per group is
shown in Table 3. Symptoms reported yielded
eight “combinations” throughout the survey
(individuals tended to repeat their pattern of
report, with 182 of 222 responders reporting
the same “combination” of symptoms
throughout the survey). Symptom report sig-
nificantly decreased during the 9 weeks
(χ2 = 486.909, p = 0.0000), yielding an odds
ratio for symptom report of 0.06 and 0.09 in
the last 2 weeks of study, respectively. This did
not coincide with decreasing ﬂuid consump-
tion over time. Reports of total “unrelated
symptoms” (used to distract the participants)
were similar in the four study groups (χ2 =
2.32, p = 0.5083).
Counting-process analysis using the step-
wise method yielded a model that included sex
(p < 0.0001) and Cu concentration received on
the day of the event (p < 0.0001). The covari-
ates of age, volume of ﬂuid intake, and water
consumed as total, plain, and mixed did not
have a significant effect on the model.
Cumulative hazard curves for increasing Cu
concentrations in test water by sex and stratiﬁed
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Table 3. Symptoms reported per group [n (%)] during the 2-month controlled Cu exposure.a
Groups by Cu concentration in water (mg/L)
0 (n = 343) 2 (n = 327)  4 (n = 355)  6 (n = 340) Total
Nausea 29/123 32/177 57/230 108/264 226/794
(23.6) (18.1) (24.8) (40.9) (28.5)
Abdominal pain 74/123 100/177 136/230 98/264 408/794
(60.2) (56.5) (37.1) (37.1) (51.4)
Diarrhea 20/123 43/177 34/230 47/264 144/794
(16.3) (24.3) (14.8) (17.8) (18.1)
Vomiting 0/123 2/177 3/230 11/264 16/794
(0.0) (1.1) (1.3) (4.2) (2.0)
aParticipants may have reported one or more symptoms on one or more occasion.
Table 2. Symptoms reported per individual [n (%)] during the 2-month controlled Cu exposure.
Groups by Cu concentration in water (mg/L)
Symptoms 0 (n = 343) 2 (n = 327)  4 (n = 355)  6 (n = 340) Total
Personsa 40 (11.7)*,** 50 (15.3)  65 (18.3)* 67 (19.7)** 222 (16.3)
Occasionsb 105/21,609 153/20,601 216/22,365 191/21,420 665/85,995
(0.5) (0.7) (1.0) (0.9) (0.8)
Totalc 123/21,609 177/20,601 230/22,365 264/21,420 794/85,995
(0.6) (0.9) (1.0) (1.2) (0.9)
aPersons reporting at least one symptom at least once. bNumber of occasions of symptom report. cTotal number of symp-
toms reported (participants may have reported one or more symptoms on one or more occasion); results expressed as
proportion of the total persons per day exposed. *p < 0.02; **p < 0.005.
Figure 2. Cumulative RR of symptoms reported during the 2-month controlled Cu exposure. Dotted lines
indicate 95% CI.
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Cu concentration (mg/L) Cu concentration (mg/L)by weeks showed a progressive decrease of risk
over time (Figure 2). Counting-process analysis
conﬁrmed results of the preliminary analysis,
which showed an increased risk of symptoms
associated with increasing Cu concentration
and with female sex. Analysis of risk differences
between sexes using the 95% CI of the cumu-
lative hazard ratio showed that the risk remains
signiﬁcantly higher from week 1 to week 4 for
all Cu concentrations (except basal 0). Figure 3
shows the RR of symptoms against exposure to
increasing Cu concentration in test water (com-
pared with no exposure); on week 1 the RR
became signiﬁcant at 4 mg/L in women (RR =
1.53; 95% CI, 1.02–2.05)] and at 6 mg/L in
men (RR = 1.9; 95% CI, 1.02–2.79). With
advancing time, the significance shifted to
higher Cu exposure, such that in week 2 for
men and week 4 for women, the Cu concen-
tration required to obtain significant differ-
ences on symptom report was > 6 mg Cu/L.
Mistakes made while preparing test waters at
home created the opportunity to evaluate the
effect of Cu exposure > 6 mg/L (actual range,
6–13 mg/L), using the same risk analysis with
counting process; this analysis involves a low
number of families (n = 126) and individuals
(n = 417). The resulting cumulative hazard
curves suggest an exponential increment of
symptoms associated to rising Cu concentra-
tion in test water (Figure 3).
Discussion
This study assessed for the ﬁrst time the effect
of controlled Cu exposure in individuals main-
taining conditions close to real daily life, pro-
viding information both on the acute
gastrointestinal responses and the effect of time
in a 2-month interval. Systematic review of Cu
effects on human health recently performed by
the National Research Council (1980) did not
reveal enough information to conclude on the
acute and subacute effects of Cu. Previous
studies intending to evaluate Cu effects on the
population failed to clarify the relation of expo-
sure Cu in tap water and digestive symptoms
(Buchanan et al. 1994; CDC 2000; Fitzgerald
1998; Knobeloch et al. 1994; Petterson and
Rasmussen 1999; Vergara et al. 1999; Zietz
et al. 2003). In the present study, two different
approaches for statistical analysis, changing Cu
concentration in drinking water from 0 to
4 mg/L, resulted in a signiﬁcant increment of
report of gastrointestinal symptoms. This con-
centration range also agrees with others previ-
ously obtained using controlled clinical trials
(Araya et al. 2001; Olivares et al. 2001).
Counting-process analysis represented a
signiﬁcant improvement in the analysis because
it treated all participants as present on every
occasion that they registered data; this repre-
sented a major concern because participating
families did not follow instructions strictly,
leaving days without registering information
when they were out of the home for 2–3 days.
A main limitation of this study is the lack of
control of the exact timing of exposure and
appearance of symptoms. This was indeed per-
formed in the above-mentioned clinical trials
that led to the dose–response curve (Araya
et al. 2001; Gotteland et al. 2001; Olivares
et al. 2001; Pizarro et al. 1999). Instead, in the
present study the main objective was to assess
to what extent this dose–response curve is
applicable when individuals are exposed to Cu
in a more realistic fashion. Only Cu concentra-
tion and sex were chosen for the model,
whereas total volume, daily Cu dose, and qual-
ity of the test waters ingested (“plain” or
“mixed infusions”) were left out of the model.
This result is most relevant because it indicates
that Cu concentration and volume are the
main determinants of response, and dose and
vehicle for Cu ingestion are less important.
Nausea has proved to be a good marker of
early response to acute Cu exposure; however,
the high frequency of abdominal pain observed
in this study was unexpected because abdomi-
nal pain was infrequently reported in previous
studies. It is difﬁcult to explain this ﬁnding; it
is possible that repeated acute Cu exposure
may be part of the explanation, but this cannot
be established by the present study.
Predominance of women in the reporting
group is another relevant ﬁnding of the study
(Figure 2); this difference was suspected in
previous studies (Araya et al. 2001; Olivares
et al. 2001) and was obtained in the present
study by using both chi-square analysis and
the counting process. Acute response to Cu
exposure is triggered very specifically in the
stomach through mechanisms that result in
vagal stimulation. Sex differences for vagal
phenomena have not been described. In gas-
tric physiology, another sex-related observa-
tion is that females have lower gastric alcoholic
dehydrogenase activity (Frezza et al. 1990);
this has been interpreted as being responsible
for the different response to alcohol of women
compared to men (Frezza et al. 1990).
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Figure 3. Cumulative RR of symptoms reported after exposure to different Cu concentrations in drinking
water compared to no Cu exposure. Dotted lines indicate 95% CI.
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Whether other sex differences occur and how
they may relate to response to Cu remain to
be clariﬁed.
Symptom reporting clearly decreased over
time both in men and women (Figure 3).
Although misreporting of symptoms due to
decreasing motivation cannot be ruled out, we
found no proof of this using several controls.
Therefore, we interpret these results as sug-
gesting an adaptive response to repeated Cu
exposure.
In this study we have established the symp-
toms, range of responses, and relevant variables
associated with repeated acute Cu exposure in
human adults. Even considering the ﬁndings
in women (who appeared to be more sensitive
to Cu exposure) and results obtained during
the ﬁrst 2 weeks of exposure (which yielded the
highest incidence of effects), the current provi-
sional guideline for drinking water (2 mg
Cu/L) set by the WHO (WHO 1993, 2003) is
safe; these data represent relevant information
for regulators who must decide on the relation-
ship of Cu exposure and the safety of drinking
water for human health.
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